Which features of a novel K+ binder should Dr Gunther consider when managing hyperkalaemia in his patients?
Session:
Why are we not achieving guideline-recommended RAASi doses in heart failure? Dr Gunther’s dilemma
Topic:
Treatment
Sponsored by AstraZeneca
Event:
ESC Congress 2018
Congress Presentation
3 more presentations in this session
Dr Gunther’s approach to heart failure management: does he need to worry about achieving guideline-recommended RAASi doses?
Overcoming barriers to optimal management of heart failure and chronic kidney disease (Panel discussion).
Access the full session
Why are we not achieving guideline-recommended RAASi doses in heart failure? Dr Gunther’s dilemma
Speakers:
Professor A. Coats
About the event
ESC 365 is supported by
